Agoracom Blog Home

Posts Tagged ‘tech stocks’

DEA Proposes New #Mhealth Rule for Substance Abuse Treatment SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:14 PM on Thursday, March 5th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

DEA Proposes New Mhealth Rule for Substance Abuse Treatment

A proposed rule change would allow providers to use mHealth tools more freely in substance abuse treatment programs, but it isn’t the rule that telehealth advocates have been anticipating.

By Eric Wicklund

March 04, 2020 – Federal officials have proposed easing restrictions on the use of mHealth in substance abuse programs – but the changes aren’t what everyone has been expecting.

Under a notice of proposed rulemaking published last month in the Federal Register, the US Drug Enforcement Agency would allow registered narcotic treatment programs (NTPs) using “mobile components” to consider those connected health elements as a coincident activity.

“The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component,” a summary of the rule states.

“This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized,” the summary continues. “These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.”

The notice is different from what telehealth and mHealth providers have been waiting for: a rule that would ease federal restrictions on the prescription of scheduled drugs via telemedicine, and one that federal officials had been expected to unveil. It even prompted Virginia Sen. Mark Warner to issue a press release congratulating the DEA on making that move.

“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,” Warner, who had sent a letter to the DEA in January, said in a press release that has since been deleted. “We need to use every tool at our disposal to ensure that individuals struggling with addiction can access the treatment they need, and telehealth is an important part of that. I am pleased the DEA has finally issued proposed rulemaking that will improve telehealth access for these patients and I hope they will work quickly to finalize this rulemaking once stakeholders have had an opportunity to weigh in.”

With the Special Registration for Telemedicine Act of 2018, which was part of the SUPPORT for Patients and Communities Act signed into law by President Donald Trump in late 2018, the DEA had until October 24, 2019 to set the ground rules for providers with a special registration to prescribe controlled substances.

That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to create that registration process. But nothing has happened since then, and the DEA and other federal agencies have refused to give any updates.

Last month’s ruling leaves healthcare providers looking for more leeway in treating substance abuse issues both pleased and disappointed. It’s a step in the right direction for programs using digital health tools, but not the leap forward that so many have been anticipating.

Source: https://mhealthintelligence.com/news/dea-proposes-new-mhealth-rule-for-substance-abuse-treatment

CLIENT FEATURE: Star Navigation $SNA.ca – Real-Time On-Board, Tracking, Flight Monitoring and Analysis Systems

Posted by AGORACOM-JC at 9:00 PM on Monday, August 19th, 2019

STAR-A.D.S.® (Airborne Data Service)

Real-time on-board, tracking, flight monitoring and analysis system that provides a virtual window into an aircraft

  • STAR-A.D.S. ® system installed on a major VVIP private operator in the Mid-East has been operating for more than one year now, to the satisfaction of the customer.
  • Discussions are being finalized to expand the installation of the STAR solution of real-time monitoring to the rest of the customers’ fleet
  • Contract for 5 aircraft installations with a scheduled flights airline in Egypt has been implemented
  • First installation is scheduled for Fall 2019 as scheduling permits, with the balance of fleet installations to match the C-check schedule of the remaining aircraft in the fleet.
  • Production of 27 STAR-A.D.S.® System units has commenced in order to meet ongoing requirements

FULL DISCLOSURE: Star Navigation Systems Group Ltd. is an advertising client of AGORA Internet Relations Corp.

Star Navigation $SNA.ca Provides a Refocused Business Strategy Update

Posted by AGORACOM-JC at 12:57 PM on Wednesday, July 24th, 2019
Sna
  • STAR-A.D.S. ® system installed on a major VVIP private operator in the Mid-East has been operating for more than one year now, to the satisfaction of the customer.
  • Contract for 5 aircraft installations with a scheduled flights airline in Egypt has been implemented.
  • Production of 27 STAR-A.D.S.® System units has commenced in order to meet ongoing requirements.

TORONTO, July 24, 2019 – Star Navigation Systems Group Ltd. (CSE: SNA) (CSE: SNA.CN) (OTCQB: SNAVF) (“Star” or the “Company”) is pleased to provide an update on its current 2019 re-focused business strategy.

The STAR-A.D.S. ® system installed on a major VVIP private operator in the Mid-East has been operating for more than one year now, to the satisfaction of the customer. Discussions are being finalized to expand the installation of the STAR solution of real-time monitoring to the rest of the customers’ fleet.

The contract for 5 aircraft installations with a scheduled flights airline in Egypt has been implemented. The first installation is scheduled for Fall 2019 as scheduling permits, with the balance of fleet installations to match the C-check schedule of the remaining aircraft in the fleet.

Production of 27 STAR-A.D.S.® System units has commenced in order to meet ongoing requirements.

An adaptation of the STAR-A.D.S. ®, System has been installed on a Bombardier Global 7500 test aircraft for almost 2 years, as part of a government Research and Development study on the effects of high altitude flights on the health of crew, passengers and equipment. Our System has proved its flexibility and adaptability, being connected in record time to existing avionics systems of the aircraft, and by being installed and interfaced with very specific sensors. While the R&D program is successfully extended for all of 2019, a derived commercial version of that application is also under discussion.

STAR-A.D.S. ® System adaptations on a fleet of small sized transport and liaison aircraft (10 passengers) and helicopters as retrofit systems were recently presented to a large Asian Defense organization. Star Navigation is actively pursuing this prospect with a proposal requested for Fall 2019, concurrent with the customer’s budgetary cycle.

The STAR M.M.I.™ Division (displays), continues to service, repair and offer case-by case new unit build for legacy LCD panels for Lockheed Martin (P3 aircraft), Northrop Grumman, and Blue Aerospace. Star qualified for these activities as a stable, long-term and direct offsets (Industrial Regional Benefit “IRB”) provider to these main US based integrators.

The STAR-ISAMM™ and STAR-LSAMM™ systems have generated a rapid and growing interest in the North American market. A Distribution and Sales agreement with AMS Heli Design has been signed, with the first contract covering 6 installations on EMS helicopters awaiting final approval by the end customer. If approved, installations are expected to start at the end of 2019.  

A Cooperation Agreement has been signed with AIRMEDIC relating to the integration of the STAR-ISAMM™ system into their fleet of fixed-wing and rotary-wing aircraft, with the possible extension of the integration of the STAR-LSAMM™ equipment into affiliated ground ambulance service providers.

STAR-ISAMM™ presentations have been made targeting Canadian Defense retrofit programs. Star has received a high level of interest from the military industry and market segments.

Two applications have been submitted to the Federal and Provincial governments for Research and Development funding covering mid-2019 to end of 2021.

As a result of the recent much needed reorganization efforts, the Company has achieved cost savings of over $500,000 per annum.

Viraf Kapadia, Chairman & CEO of Star said:

“A significant part of the recent corporate reorganization involves the Sales Department at Star, which has not performed to expectations. The Company is actively working on building a new Sales team with proven aviation experience, drive and commitment. There have also been many developments on the technical and product front. The Company has recently successfully completed its regular AS 9100 Rev “D” quality audit. Additionally, stages 1 and 2 of ISO 13485 & MDSAP (Medical Device for Single Audit Program) for medical devices are also now completed and awaiting certification. We are in the process of obtaining Health Canada and FDA licenses required for STAR-ISAMM™ and STAR-LSAMM™, and are working on various new G3 STAR-A.D.S.® STCs, as well as on improvements to our GUI. We have three products awaiting certification, and we have just passed CGR inspection review at our new premises. I am proud to say that our Company is able to demonstrate a quality profile that offers a potential customer a blend of the Aerospace standard AS 9100 Rev “D”, ISO 9001:2015 and the medical standard ISO 13485. This is a unique combination that may open many sales opportunities.”

About Star Navigation:

Star Navigation Systems Group Ltd. owns the exclusive worldwide license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®, the heart of the STAR-A.D.S. ®, STAR-ISAMM™ and STAR-LSAMM ™ Systems. Its real-time capability of tracking performance trends and predicting incident-occurrence enhances aviation safety and improves fleet management while reducing costs for the operator.

Stars’ M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defence and commercial aviation industries worldwide. These displays are found on aircraft and simulators, from C-130 aircraft, to Sikorsky and Agusta Westland helicopters, as examples.

Stars’ subsidiary, Star-Isoneo Inc. is a specialised software firm, developing complex solutions in engineering, simulation and development for Canadian customers. Star-Isoneo works closely with Star in the development of the Company’s MEDEVAC (STAR-ISAMM™ and STAR- LSAMM™) applications of the patented STAR-A.D.S. ® technology, and on its current R&D program with Bombardier.

Certain statements contained in this News Release constitute forward-looking statements. When used in this document, the words “may”, “would”, “could”, “will”, “expected” and similar expressions, as they relate to Star or its management are intended to identify forward-looking statements. Such statements reflect Star’s current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause Star’s actual performance or achievements to vary from those described herein. Should one or more of these factors or uncertainties materialize, or should assumptions underlying forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Star does not assume any obligation to update these forward-looking statements, except as required by law.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of the content of this release.

Please visit www.star-navigation.com or contact

Viraf S. Kapadia, CEO (416) 252-2889 Ext. 230 

[email protected]

Good Life Networks $GOOD.ca – Confused About What Makes Something Programmatic? It Needs These 3 Features $RUBI $AT.ca $TRMR $FUEL

Posted by AGORACOM-JC at 9:55 AM on Tuesday, April 2nd, 2019
SPONSOR: Good Life Networks (GOOD:TSX-V) Video advertising is the future! Company’s A.I. makes 80,000 calculations / second, targeting 750 million users to deliver higher prices and volume. Company announced combined trailing 12 month revenue at just over $40 Million, $7.9M EBITDA, $3 Million net income. Click here for more information.
GOOD: TSX-V

—————————

Confused About What Makes Something Programmatic? It Needs These 3 Features

  • Programmatic, an algorithmic approach to putting media placements in front of the right user, prioritizing reach over environment.
  • Programmatic gave new life to display advertising

By Kathleen Petersen

Display media—banner ads, specifically—has seen its share of ups and downs. In the mid-90s when digital advertising became a thing, banner ads were one of the first formats.

I can imagine those initial advertising agency media teams saying to clients, ” We ran this little box on our webpage and look how many clicks it got! Look how many people used this little box to visit your site!” But then, of course, consumers got used to banner ads. They were no longer a novelty, and people stopped clicking. Instead, they started saying things like, “Those ads are annoying,” or “I don’t even notice those ads” (although studies prove they do). Everyone hated them, and display advertising budgets started to dwindle.

Enter a new buying strategy: programmatic, an algorithmic approach to putting media placements in front of the right user, prioritizing reach over environment.

Programmatic gave new life to display advertising. Suddenly banners and video weren’t as expensive. They were more sophisticated in targeting and were easier to optimize based on an end goal (translation: better than running the impressions and assuming they do something good that can’t be proven). By 2010, sophisticated digital advertisers were funneling large amounts of their display media budgets to this approach. Today it’s all media teams talk about: programmatic banners, programmatic video, programmatic native, and now, programmatic TV, programmatic out of home and programmatic mail.

Hold up, though—that’s not programmatic. Programmatic has gone beyond what it is at its roots … to a buzzword for seemingly any media with a bit of data behind it.

Programmatic has gone beyond what it is at its roots—a modernized and automated approach to media buying—to a buzzword for seemingly any media with a bit of data behind it.

There are three pieces required to make something programmatic:

The ability to combine multiple layers of data

Demographics and interest targeting have been in digital media’s corner for a while. With a programmatic approach, you can slice and dice those targeting technologies, add others and stack them all on top of each other. This includes first-, second- and third-party data. The ability to determine if a person is within our target audience based on their demographics, what their interests are, where they are geographically, how often they travel, what type of credit card they use, how long they’ve owned their home and on and on is right up the programmatic alley.

Real-time bidding

Before programmatic buying was available, display buyers would identify sites with the highest reach against their target audience and buy a set number of impressions directly from said site. This isn’t the case with programmatic. Now we’re in an exchange, bidding to get the best placements in front of the most qualified users and paying only a penny more than the next advertiser we won the bid from. Buying programmatically is much more efficient and garners a far wider reach. You’re finding the best available user, regardless of the content they’re in. Not to say that premium environment prioritized in the days of old isn’t important. White lists and premium marketplaces can get you high-quality contextual placements while using a programmatic approach.

On the fly optimization

At one time, ads ran and we served X number of impressions or ads ran, we ran X number of impressions and Y people clicked on them was the furthest extent to which you could report on your display media performance. You could take this information and adjust your strategy for next time. But with programmatic, algorithms are getting continuously smarter, and you’re able to optimize based on a multitude of factors. So now your campaign can improve as time goes on instead of waiting until the end so you know what to do better next time. Budgets can be prioritized according to what users are doing post-exposure in real-time. For example, if placement A is performing better than placement B, the algorithm will shift bids to prioritize the better performer.

These three features are possible with digital media, but at this point, it isn’t possible for traditional media channels to pull all of them off. As time and technology goes on, traditional media channels will get closer to achieving this. Television, with the use of smart TVs and OTT devices is the closest.

Data available for television targeting has become much more sophisticated in recent years, but they are lacking in real-time bidding. Most TV being bought “programmatically” is still purchased two weeks ahead of time, not at the exact second exposure is available. And while we can now use data to identify high indexing programming, the targeting isn’t 1-to-1 unless it is addressable. Out of home is in second place, and will be easier to achieve on small digital boards (think ATM or gas station screens) where a user can be identified by their phone’s proximity to the screen.

So, when you hear a media channel being referred to as programmatic, make sure the term is being used correctly. Advances in technology in digital and traditional channels that allow our campaigns to be more precise are very exciting and enticing, but check against these three features to ensure you know how your media dollars are being used.

Source: https://www.adweek.com/programmatic/confused-about-what-makes-something-programmatic-it-needs-these-3-features/

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 9:45 PM on Sunday, March 31st, 2019

Global Leaders in Mobile ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

Good Life Networks $GOOD.ca – Identity and Advanced TV Have Reshaped Video Advertising $TTD $RUBI $AT.ca $TRMR $FUEL

Posted by AGORACOM-JC at 3:12 PM on Thursday, March 21st, 2019
SPONSOR: Good Life Networks (GOOD:TSX-V) Video advertising is the future! Company’s A.I. makes 80,000 calculations / second, targeting 750 million users to deliver higher prices and volume. Company announced combined trailing 12 month revenue at just over $40 Million, $7.9M EBITDA, $3 Million net income. Click here for more information.
GOOD: TSX-V

—————————

It used to be about cutting time off content, but that’s changed

By Victor Wong

Using longer videos in strategies may be the future of this sect of the industry.

Just when creatives wrapped their heads around data and programmatic, new technology is about to reshape storytelling again. While those first disruptive trends changed display and rich media ads, video ads remained largely unaffected. In fact, video ads haven’t actually changed in decades, aside from getting shorter and running on different types of screens.

Whereas innovation used to be measured in the seconds shaved—from 60-second to 30-second to 15-second to 6-second—now we’re seeing the actual video ad formats evolve as two new trends converge: advance TV and identity. These powerful forces have already reshaped media buying as more ad dollars shift from offline to digital formats, but now they are in the midst of transforming the creative experience. Here’s how:

Pause-vertising

Creative agencies now need to begin thinking about longer form videos and know they can break up the content into mini-episodes of ads.

As more video is viewed on advance TV media formats, such as CTV and OTT services that run on computers or phones, new possibilities have emerged. Whereas linear television ads were built around filling scheduled commercial breaks, CTV and OTT experiences have built-in, widely-used pausing functionality, creating a new form of commercial break and screen layout. Imagine seeing an ad for your favorite brand appear quickly when you hit pause (or unpause) for quick breaks to respond to a message or grab a snack. Hulu and AT&T’s Xandr advertising business both plan to introduce a form of this “pause-vertising” this year.

Second screen

Another idea is second screen ads where a brand wants to take advantage of the fact that viewers are often watching TV while using another device. Nowadays, many devices can be connected through an identity graph (from a telco, a data provider, etc.) that links registration information like billing addresses for different signed in services on different devices. The possibilities now include using addressable television media buying to target TVs registered to households that have been shown to have the brand’s app so that you can run TV ads that encourage specific interaction with apps or drive users to the app for info rather than trying to cram everything into a TV spot.

Ad episodes

Perhaps an even more powerful application of identity is creating episodic ads where, rather than trying to cram all the content into one spot, you can tell a story over several ad episodes across different screens and time. Historically with TV ads and even digital video ads, brands had no idea whether a viewer had already seen an ad or not. Now with cross-device IDs, brands can keep track of whether a viewer or household had been served an episode already, and if so, to move on to the next episode in the sequence even if the user is switching between devices. Without a people-based identity graph, message sequencing would be a nightmare of repeat instances of the first ad episode because the advertiser wouldn’t realize it’s the same household or viewer.

To make these ideas possible, brands will need to work with creative agencies and video media inventory owners that have invested in addressable television, OTT and identity. Creative agencies will need to adapt creative for the new pause-vertising formats, knowing that it could be on loop until a user returns, or focus messaging around what to do during this explicit viewing break. Platform owners will need to identify what percentage of a brand’s app users it can reach with TV media so that the brand can determine if TV campaigns should be for app acquisition or designed to drive second screen usage or execute addressable buys for both. Creative agencies now need to begin thinking about longer form videos and know they can break up the content into mini-episodes of ads.

Executing these new forms of creative don’t change what makes a good story, but they do give brands new ways of telling a good story beyond the standard 30-second one-size-fits-all spots. As more video watching moves from pure linear to more digital, the industry is at a pivotal moment to reinvent the ad experience and make it fit more natively in the new technology. Only then can video ads reach their full new potential.

Source: https://www.adweek.com/tv-video/identity-and-advanced-tv-have-reshaped-video-advertising/

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:08 PM on Tuesday, March 19th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Check Out Our Recent Interview

 FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CardioComm Solutions’ $EKG.ca HeartCheck(TM) Device Enters Final FDA Review Phase

Posted by AGORACOM-JC at 9:45 AM on Tuesday, January 29th, 2019

HeartCheck(TM) CardiBeat and GEMS(TM) Mobile review results expected in late February

  • Completed a request for additional information from the US Food and Drug Administration for the Company’s premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application.

Toronto, Ontario–(January 29, 2019) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company“), a leading global provider of consumer heart monitoring and electrocardiogram (“ECG“) acquisition and management software solutions, confirms it has completed a request for additional information from the US Food and Drug Administration (“FDA“) for the Company’s premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application.

The Company had submitted a letter of revocation of their supplementary information submission on December 26, 2018 in compliance with the FDA’s directive. The Company has now provided the FDA a restatement of their response for additional information as of January 23, 2019, which the FDA has confirmed received. The FDA will now have 31 days to complete the 510(k) review of CardioComm’s restated submission.

To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device integrations please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]

[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/42519

CLIENT FEATURE: CardioComm Solutions, Inc. $EKG.ca – The heartbeat of Cardiovascular Medicine and Telemedicine

Posted by AGORACOM-JC at 2:21 PM on Thursday, December 27th, 2018
EKG: TSX-V

The heartbeat of cardiovascular medicine and telemedicine

  • Specializing in the software engineering of computer based electrocardiogram (heart monitoring) management and reporting software
  • Software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings
  • ECGs are electrical recordings of the heart and performing an ECG is one of the most common diagnostic tests performed
  • Successfully launched technologies that enable the use of new medical devices and communication portals utilizing internet and cellular based technologies for the recording, transmission and viewing of ECGs

Recent Highlights

CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More

  • Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
  • Completed its response to the USA Food and Drug Administration for additional information following the Company’s filing of its premarket notification 510(k)
    • Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
  • HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company

Launched 12-Lead ECG Smart Wearable Garment Monitoring Solution Read More

  • Announced joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd.

Company to Receive Royalty Payments from Biotricity Read More

  • Confirmed progress on a royalty licencing agreement with Biotricty Inc.
  • Royalty payment phase became active following confirmation that all necessary clearance and software development pre-conditions have been achieved
  • Royalty fees are due from the use of the ECG software Cardiocomm developed, or any derivative products, on a per patient monitored basis

First Company to Receive Approval for ECG Product Sales Direct to Consumers Read More

  • CardioComm was the first company to be approved to sell an ECG product directly to consumers in North America as evidenced by OTC Class II medical device clearances by both the United States Food and Drug Adminstration and Health Canada in 2012
  • HeartCheck ECG PEN is currently available for OTC sales on the shelves of Canadian pharmacy chain Shoppers Drug Mart.

Completed HeartCheck(TM) Clinical Validation for Long-Term, Self-Managed, Remote Monitoring of Atrial Fibrillation Patients Post-Ablation Read More

  • Moved into routine clinical use following completion of a long-term, remote arrhythmia monitoring pilot in high risk patients.
  • PACE cardiologists have been prescribing use of the HeartCheck™ ECG PEN and ECG Handheld Monitor to their patients to provide up to one year of enhanced remote patient monitoring for arrhythmias in addition to use of conventional but term-limited Holter and event monitoring.

Products

HeartCheck™ Pen

The HeartCheck™ PEN handheld ECG device is the only device of its kind cleared by the FDA for consumer use.


✓ Monitor For Arrhythmias Anywhere
✓ Web Access to a Qualified Physician
✓ No Prescription Required

 
The pocket-sized PEN allows you to take heart readings from anywhere, the moment symptoms appear.

The HeartCheck™ ECG Device

The FDA-cleared HeartCheck™ ECG device is portable, easy to use and can store up to 200 thirty second ECG readings.

Whether at home, the gym or at the office, the HeartCheck™ ECG Device with SMART Monitoring can help detect and monitor arrhythmias from wherever you are.  

  Features & Benefits
✓ SMART Monitoring ECG Interpretations
✓ Cleared by the Food and Drug Administration (FDA)
✓ Easy to use
✓ Accurate heart readings in only 30 seconds
✓ Store up to 200 ECGs

Company Accolades

CLIENT FEATURE: Kuuhubb $KUU.ca Mobile Video Gaming And Apps For Women; $US 5.5M Quarterly Revenues, 33M Downloads, 7M Monthly Active Users $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 3:39 PM on Tuesday, October 30th, 2018

KUU: TSX-V

HIGHLIGHTS

  • $US 5.5 Million Quarterly Revenues
  • 200 Million Quarterly Sessions
  • 33 Million Downloads
  • 7 Million Monthly Active Users (MAU)
  • Partnerships: Kellogg’s and Samsung
  • Research Reports Target Significantly Higher Prices
  • Aggressive Global Growth Plans Now Underway
  • Japan Already Established Mobile Revenues
  • Have Surpassed The USA For 3 Consecutive Years

FULL DISCLOSURE: Kuuhubb is an advertising client of AGORA Internet Relations Corp.